Pharmaceutical lifecycle management : making the most of each and every brand /
Ellery, Tony
Pharmaceutical lifecycle management : making the most of each and every brand / Tony Ellery and Neal Hansen - Hoboken, New Jersey : John Wiley & Son, Inc., c2012 - xxii, 389 pages : illustrations ; 24 cm.
Includes bibliographical references and index.
pt. A. Lifecycle management business environment -- pt. B. Lifecycle management regulatory and legal environment -- pt. C. Patents and exclusivities -- pt. D. Developmental LCM -- pt. E. Commercial LCM -- pt. F. Biologics and biosimilars -- pt. G. The integrated brand LCM strategy and its implementation -- pt. H. Integrating LCM with portfolio management.
A comprehensive guide to optimizing the lifecycle management of pharmaceutical brandsThe mounting challenges posed by cost containment policies and the prevalence of generic alternatives make optimizing the lifecycle management (LCM) of brand drugs essential for pharmaceutical companies looking to maximize the value of their products. Demonstrating how different measures can be combined to create winning strategies, Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand explores this increasingly important field to help readers understand what they can--and must--do to get.
9780470487532
DRUG APPROVAL -- ECONOMIC ASPECTS
HD 9666.5 .E45 2012
Pharmaceutical lifecycle management : making the most of each and every brand / Tony Ellery and Neal Hansen - Hoboken, New Jersey : John Wiley & Son, Inc., c2012 - xxii, 389 pages : illustrations ; 24 cm.
Includes bibliographical references and index.
pt. A. Lifecycle management business environment -- pt. B. Lifecycle management regulatory and legal environment -- pt. C. Patents and exclusivities -- pt. D. Developmental LCM -- pt. E. Commercial LCM -- pt. F. Biologics and biosimilars -- pt. G. The integrated brand LCM strategy and its implementation -- pt. H. Integrating LCM with portfolio management.
A comprehensive guide to optimizing the lifecycle management of pharmaceutical brandsThe mounting challenges posed by cost containment policies and the prevalence of generic alternatives make optimizing the lifecycle management (LCM) of brand drugs essential for pharmaceutical companies looking to maximize the value of their products. Demonstrating how different measures can be combined to create winning strategies, Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand explores this increasingly important field to help readers understand what they can--and must--do to get.
9780470487532
DRUG APPROVAL -- ECONOMIC ASPECTS
HD 9666.5 .E45 2012